Skip to main content
. 2022 Jul 25;61(10):1457–1469. doi: 10.1007/s40262-022-01147-w

Fig. 4.

Fig. 4

Distribution of steady-state AUC by incidence of AESIs. No significant relationships between brensocatib exposure and the incidence of AESIs were evident. AESI adverse event of special interest, AUC area under the concentration-time curve